Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

87 results about "2,2,2-Trifluoroethanol" patented technology

2,2,2-Trifluoroethanol is the organic compound with the formula CF₃CH₂OH. Also known as TFE or trifluoroethyl alcohol, this colourless, water-miscible liquid has a smell reminiscent of ethanol. Due to the electronegativity of the trifluoromethyl group, this alcohol exhibits a stronger acidic character compared to ethanol. Thus, TFE forms stable complexes also with heterocycles (e.g. THF or pyridine) through hydrogen bonding.

Nano fibrous tissue engineering blood vessel and preparation thereof

The invention relates to a tissue engineering material and a preparation method thereof, in particular to a nano fiber tissue engineering blood vessel and a preparation method thereof. The invention consists of a three-dimensional reticular non-woven film formed by an inner layer of nano fiber and an outer layer of nano fiber; the inner layer of the blood vessel is natural polymer, wherein, calculated by weight, 40 percent to 80 percent is fibroin, 20 percent to 50 percent is gelatine, 0 percent to 20 percent is extracellular matrix protein; while the outer layer of the blood vessel is synthetic polymer. The preparation method is that the natural polymer is dissolved in trifluroroethyl and other solution, while the synthetic polymer is dissolved in hexafluoroisopropanol and other solution, which are respectively prepared into spinning solution; the static electricity spinning technique is adopted to subsequently form the inner and the outer layers on a gather roller; cross-linked treatment is conducted after the inner and the outer layers are taken down, to prepare the nano fiber tissue engineering vessel. The inner layer can simulate the structure of the extracellular matrix, provide good environment for endothelial cells to grow, support adhesion, proliferation and differentiation of the cells, and is good for endothelization of the blood vessel; and the outer layer has good mechanical performance.
Owner:SUZHOU UNIV

Paclitaxel loaded sustained release nano fiber and preparation method and use thereof

The invention relates to a paclitaxel-loaded sustained release nano-fibre material which comprises the components of bio-degradable polymer material and pure paclitaxel, the mol ratio of which is 1.33 to 10. The diameter of the nano-fibre is 90nm to 1.44micrometer, and the drug-loading rate can be regulated within the range of 0 percent to 100 percent. The preparation of the nano-fibre comprises the steps as follows: (1) the bio-degradable polymer material is solved in organic solvent and stirred to be solved completely to obtain lamella spinning solution A; (2) the white pure paclitaxel powder is solved in trifluoroethanol and stirred to be solved completely to obtain core spinning solution B; (3) clear transparent solutions A and B are respectively added into two injectors; the speed of a microinjection pump, the voltage of a static generator and the receiving distance between a grounded aluminum foil and a spinning needle are adjusted, and unordered drug-loaded nano-fibre is obtained by a coaxial electrostatic spinning technology. A nanometer control release system composed by the drug-loaded nano-fibre effectively controls the sustained release of the drug and is applied to the preparation of the drug for remedying malignant tumor.
Owner:DONGHUA UNIV

Method for preparing exenatide

The invention relates to a method for preparing exenatide, and solves the problems that cost is high, yield is low, impurity (des-Glu<15>, Glu<16>-exenatide) content is relatively large and large-scale production cannot be realized in the prior art. The concrete steps comprise: A) taking amino resin as initial resin, employing an Fmoc solid-phase synthesis method, according to the peptide sequence of the exenatide main chain to successively couple with amino acids with Fmoc protection at N terminal and with protected side chains, wherein in the amino acid coupling reactions of the peptide sequence 15-17, a solution DMF is added with 2,2,2-trifluoroethyl alcohol accounting for 20% by volume of the solution and 1.5 mol/L of urea; and B) after peptide resin is subjected to cracking, employing a reverse-phase filling material for first purification, and employing anion resin for second purification, desalinating to enable the content of impurities des-Glu<15>, Glu<16>-exenatide to be reduced to 0.1% or less, and performing freeze drying, so as to obtain exenatide. The method is a low-cost preparation technology suitable for large-scale production of exenatide with high purity, and the technology is capable of effectively controlling the content of des-Glu<15>, Glu<16>-exenatide and does not influence the yield of exenatide.
Owner:ADLAI NORTYE BIOPHARMA CO LTD

Preparation method of antigen determinant/DOX double-template molecularly imprinted fluorescent nanoparticles with alpha-helix structure

The invention discloses a preparation method of antigen determinant / doxorubicin hydrochloride (DOX) double-template molecularly imprinted fluorescent nanoparticles with an alpha-helix structure. Fluorescent nano silicon spheres wrapping silicon nano-particles are used as a carrier, P32 protein N-terminal conformation 9 peptides and doxorubicin hydrochloride are used as double-template molecules, and the double-molecular imprinted nano particles are prepared by adopting a precipitation polymerization method. According to the invention, the Si nano particles are wrapped in silicon dioxide to prepare fluorescent nano silicon spheres and the fluorescent double-template molecularly imprinted nano particles, and the fluorescence characteristic can be used for fluorescence imaging of tumor cells.A polypeptide with an alpha-helix structure constructed by using trifluoroethanol is used as a template molecule, so that target identification of target tumor cells can be effectively improved. Thenano particles are prepared by adopting the conformation polypeptide and the doxorubicin hydrochloride as double templates, targeted medicine delivery is realized while targeted specific recognition of tumor cells is realized, the amount of medicines reaching target sites is increased, side effects are reduced, the medicine utilization rate is improved, and the treatment effect is enhanced.
Owner:NANKAI UNIV

Method for extracting and separating trifluoroethanol and water azeotrope by using porous ionic liquid

The invention relates to a method for extracting and separating trifluoroethanol and water azeotrope by using a porous ionic liquid, which comprises the following steps: combining an MOF material ZIF-8 with imidazole and pyridine ionic liquid to form the porous ionic liquid, and extracting and separating trifluoroethanol and water by using the porous ionic liquid as an extracting agent to obtain an upper-layer water phase and a lower-layer porous ionic liquid phase; and extracting the upper-layer water phase by using the porous ionic liquid, and circularly extracting for 5 times, so that the content of the trifluoroethanol in the upper-layer water phase is almost zero, and the effective separation of the trifluoroethanol and the water is realized. performing, by using ethyl acetate, back extraction on the lower-layer porous ionic liquid phase, continuously adding trifluoroethanol and water with the same proportion into the back-extracted lower-layer porous ionic liquid phase for extraction, wherein the porous ionic liquid still shows very high extraction and separation capacity after 8 times of cyclic extraction. The ZIF-8 and the ionic liquid used in the invention are simple and convenient to prepare, wherein the porous ionic liquid extraction agent is high in extraction efficiency, high in cyclic extraction capacity, environment-friendly and reusable, the extraction process is low in energy consumption, and the recovery rate of trifluoroethanol can reach 96.9%.
Owner:SHANDONG UNIV OF SCI & TECH

High-purity fluorine-containing organophosphorus flame retardant and preparation method thereof

The invention relates to a high-purity fluorine-containing organophosphorus flame retardant and a preparation method thereof. The preparation method comprises the following steps: (1) preparation of trifluoroethyl phosphate, namely adopting phosphorus oxychloride and trifluoroethanol of which the total molar weight ratio is (1:3)-(1:6), adding a catalyst which accounts for 2%-10% of total weight of reactants, carrying out catalytic reaction at the temperature of 10-90 DEG C for 2-16 hours, carrying out reduced pressure distillation for 1-5 hours to remove insufficiently reacted phosphorus oxychloride and trifluoroethanol after the catalytic reaction is completed, and then carrying out suction filtration to obtain the catalyst capable of being recycled and a crude trifluoroethyl phosphate product; (2) purification and refining of the trifluoroethyl phosphate, namely refining phosphate by adopting a continuous rectification process, adding a drying agent to the crude trifluoroethyl phosphate product so as to remove moisture contained in a to-be-purified substance, rectifying by introducing into a low-boiling removing rectifying column, condensing high-purity trifluoroethyl phosphate rectified through multi-times column chromatography into liquid, namely the high-purity trifluoroethyl phosphate flame retardant contained in the electrolyte of a lithium ion secondary battery, by virtue of a condenser, wherein the purity is more than or equal to 99.9%, and the yield is more than or equal to 92%.
Owner:TIANMEN FULIN JINFU FINE CHEM

Method for synthesizing chiral 3-trifluoromethyl-3, 4-dihydroquinoxalinone by palladium-catalyzed asymmetric hydrogenation

The invention relates to a method for synthesizing chiral 3-trifluoromethyl-3, 4-dihydroquinoxalinone by palladium-catalyzed asymmetric hydrogenation. A catalytic system is a chiral diphosphorus complex of palladium, and the reaction conditions are as follows: the temperature is 0-80 DEG C, the solvent is 2, 2, 2-trifluoroethanol or hexafluoroisopropanol, the pressure ranges from 100 psi to 1000 psi, the ratio of the substrate to the catalyst is 33/1, the used metal precursor is palladium trifluoroacetate, and the used chiral ligand is a chiral diphosphorus ligand. The preparation method of the catalyst comprises the following steps: stirring a metal precursor of palladium and a chiral diphosphine ligand in acetone at room temperature, and then carrying out vacuum concentration to obtain the catalyst. Corresponding chiral dihydroquinoxalinone containing trifluoromethyl can be obtained by hydrogenating quinoxalinone containing trifluoromethyl, and the enantiomeric excess of the dihydroquinoxalinone containing trifluoromethyl can reach 99%. The method is simple, convenient and practical to operate, high in enantioselectivity and high in yield, and the reaction has green atom economyand is environmentally friendly.
Owner:DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products